Zdrowie i gospodarka · 24/06/2026
FDA Announces Availability of Draft Guidance for Master Protocols in Drug and Biological Product Development
The FDA has released a revised draft guidance for industry on master protocols for drug and biological product development, aiming to clarify the use of master protocols in clinical trials and regulatory submissions.